[go: up one dir, main page]

SG127405A1 - Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation - Google Patents

Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation

Info

Publication number
SG127405A1
SG127405A1 SG200607929A SG200607929A SG127405A1 SG 127405 A1 SG127405 A1 SG 127405A1 SG 200607929 A SG200607929 A SG 200607929A SG 200607929 A SG200607929 A SG 200607929A SG 127405 A1 SG127405 A1 SG 127405A1
Authority
SG
Singapore
Prior art keywords
lactic acid
acid bacteria
oral inflammation
reducing oral
gum bleeding
Prior art date
Application number
SG200607929A
Other languages
English (en)
Inventor
Eamonn Connolly
Bo Moellstam
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of SG127405A1 publication Critical patent/SG127405A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058Chewing gums
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063Periodont
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
SG200607929A 2004-06-14 2005-06-14 Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation SG127405A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58027904P 2004-06-14 2004-06-14
US11/147,880 US20050281756A1 (en) 2004-06-14 2005-06-08 Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation

Publications (1)

Publication Number Publication Date
SG127405A1 true SG127405A1 (en) 2006-12-29

Family

ID=35480800

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200607929A SG127405A1 (en) 2004-06-14 2005-06-14 Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation

Country Status (19)

Country Link
US (2) US20050281756A1 (es)
EP (2) EP2229949B1 (es)
JP (1) JP2008502714A (es)
KR (1) KR20070018985A (es)
CN (2) CN1980683B (es)
AT (2) ATE537837T1 (es)
AU (2) AU2005251673C1 (es)
CA (1) CA2567867C (es)
DE (1) DE602005023463D1 (es)
DK (2) DK2229949T3 (es)
ES (1) ES2351153T3 (es)
IN (1) IN2006DE07651A (es)
NZ (1) NZ551860A (es)
PL (1) PL1765282T3 (es)
PT (1) PT1765282E (es)
SG (1) SG127405A1 (es)
SI (2) SI1765282T1 (es)
WO (1) WO2005120527A1 (es)
ZA (1) ZA200700211B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2553636T3 (es) * 2006-03-07 2015-12-10 Nestec S.A. Mezcla simbiótica
CN102115721B (zh) * 2008-05-08 2012-09-26 景岳生物科技股份有限公司 具有抗炎活性的乳杆菌分离株及其用途
DK2437758T3 (da) * 2009-06-03 2014-07-21 Chr Hansen As Bakterie thyA(-) mutanter med forøget vitamin K
US20110014324A1 (en) * 2009-07-10 2011-01-20 Christoffer Lundqvist Product for the storage of freeze-dried lactic acid bacteria mixed with oral rehydration solution
CN102470151B (zh) 2009-07-16 2013-07-24 国立大学法人广岛大学 口腔内疾病的预防、改善或治疗剂
US20110293710A1 (en) * 2010-02-02 2011-12-01 Delphine Saulnier Immunomodulatory properties of lactobacillus strains
US20130022586A1 (en) * 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine
DE102011116325B4 (de) * 2011-10-14 2016-03-10 orochemie GmbH + Co. KG Neue Milchsäurebakterien und diese enthaltende Zusammensetzungen
ES2813524T3 (es) * 2011-12-28 2021-03-24 Amgen Inc Método para tratar la pérdida de hueso alveolar mediante el uso de anticuerpos antiesclerostina
RU2492851C1 (ru) * 2012-08-02 2013-09-20 Сергей Владимирович Кузнецов Способ профилактики и лечения воспаления в ротовой полости после стоматологической хирургической операции
US11020441B2 (en) * 2016-01-19 2021-06-01 Symrise Ag Probiotics for use as anti-inflammatory agents in the oral cavity
US20170273334A1 (en) * 2016-03-25 2017-09-28 Zoe Kapp Method of Naturally Decomposing Chewing Gum
EP3351259A1 (en) 2017-01-18 2018-07-25 Symrise AG Probiotics for aggregation with disease-associated species in the oral cavity
US12246078B2 (en) 2017-09-14 2025-03-11 Gerald P. Curatola Oral care formulations and methods for use
WO2020001747A1 (en) 2018-06-26 2020-01-02 Symrise Ag Lactobacillus plantarum for skin care
KR102720199B1 (ko) 2022-06-30 2024-10-22 대한제당 주식회사 우수한 프로폴리스 내성을 가진 신규 구강 유산균 락토바실러스 루테리 tsb-r7
CN118217218A (zh) * 2024-04-01 2024-06-21 天津大学 预防和治疗牙周炎的益生菌牙膏及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1514469A (en) * 1974-08-01 1978-06-14 Beecham Group Ltd Oral hygiene compositions
US5413960A (en) * 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
US5458875A (en) 1990-06-15 1995-10-17 Biogaia Ab In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry
US5534253A (en) 1995-06-07 1996-07-09 Biogaia Ab Method of treating enteropathogenic bacterial infections in poultry
AU718040B2 (en) * 1995-12-21 2000-04-06 Abbott Laboratories Use of lactobacillus reuteri to inhibit cryptosporidiosis in mammals
US5837238A (en) * 1996-06-05 1998-11-17 Biogaia Biologics Ab Treatment of diarrhea
US5800813A (en) * 1996-11-12 1998-09-01 Biogaia Biologics Ab Treatment of cryptosporidium infections
KR100266752B1 (ko) * 1997-08-07 2001-03-02 오종석 인체 구강내 치태형성을 억제하는 신규한 유산균
KR19990024297A (ko) * 1997-08-07 1999-04-06 오종석 인체 구강내 치태형성을 억제하는 신규한 유산균
US20030077814A1 (en) * 1997-08-07 2003-04-24 Oh Jong Suk Novel lactic acid bacteria
US6100388A (en) * 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
US6080401A (en) * 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
SI1312667T1 (sl) * 2000-08-25 2009-04-30 Wakamoto Pharma Co Ltd Probiotiäśni produkti, ki vsebujejo sev l. salivarius
JP4203855B2 (ja) * 2002-03-29 2009-01-07 株式会社フレンテ・インターナショナル 乳酸菌を有効成分とする生菌製剤および乳酸菌含有食品
JP2003299480A (ja) * 2002-04-09 2003-10-21 Hiroki Futagawa 虫歯予防用細菌、虫歯予防用食品、虫歯予防用口腔洗浄剤及びヨーグルトの製造方法
US7105336B2 (en) 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
CN1216145C (zh) * 2002-11-07 2005-08-24 上海新立工业微生物科技有限公司 一种嗜热乳酸杆菌以及采用该菌种生产l-乳酸的方法
US6872565B2 (en) * 2003-01-29 2005-03-29 Biogaia Ab Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries

Also Published As

Publication number Publication date
PL1765282T3 (pl) 2011-03-31
CN102851350A (zh) 2013-01-02
DK2229949T3 (da) 2012-02-06
DK1765282T3 (da) 2011-01-03
EP2229949A1 (en) 2010-09-22
KR20070018985A (ko) 2007-02-14
AU2010201837A1 (en) 2010-05-27
AU2005251673C1 (en) 2010-12-02
CN1980683B (zh) 2012-10-24
EP1765282A1 (en) 2007-03-28
ES2351153T3 (es) 2011-02-01
CA2567867A1 (en) 2005-12-22
ZA200700211B (en) 2008-04-30
WO2005120527A1 (en) 2005-12-22
CN102851350B (zh) 2015-12-16
SI2229949T1 (sl) 2012-04-30
AU2005251673A1 (en) 2005-12-22
US20090238774A1 (en) 2009-09-24
PT1765282E (pt) 2010-12-16
IN2006DE07651A (es) 2007-08-17
HK1101356A1 (en) 2007-10-18
CN1980683A (zh) 2007-06-13
NZ551860A (en) 2009-12-24
EP1765282B1 (en) 2010-09-08
ATE480248T1 (de) 2010-09-15
HK1180372A1 (zh) 2013-10-18
EP2229949B1 (en) 2011-12-21
SI1765282T1 (sl) 2010-12-31
AU2005251673B2 (en) 2010-03-04
JP2008502714A (ja) 2008-01-31
DE602005023463D1 (de) 2010-10-21
CA2567867C (en) 2012-04-10
ATE537837T1 (de) 2012-01-15
US20050281756A1 (en) 2005-12-22

Similar Documents

Publication Publication Date Title
SG127405A1 (en) Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
WO2009144458A3 (en) Food product
MY155418A (en) Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
WO2008054208A3 (en) Use of nutritional compositions for preventing disorders
WO2013072932A3 (en) Oral care compositions
TW200519075A (en) Novel compounds
DE60216614D1 (de) Zusammensetzung mit bakteriostatischen und bakteriziden eigenschaften gegen bakterielle sporen und zellen und verfahren zu deren verwendung zur behandlung von lebensmitteln
TW200736213A (en) Dicarboxylic acid derivatives and their use
TW200630336A (en) Novel compounds
TW200621690A (en) Novel compounds
WO2005018342A8 (en) Compositions and methods for the maintenance of oral health
UA91541C2 (ru) Бактерицидные макроциклы v, которые содержат амидные группы
MXPA05009688A (es) Derivados de naftiridina como agentes antibacterianos.
WO2009050677A3 (fr) Utilisation de bacteries lactiques pour la prevention et/ou le traitement de pathologies cutanees
PT1749517E (pt) Composição farmacêutica estável compreendendo a forma iv de linezolida
ATE464045T1 (de) Zusammensetzung aus milchsäure und lactoferrin
IL194353A0 (en) Lysobactin amides
MY162652A (en) Novel use of quinolone antibiotics
EP1942170A4 (en) ACCELERATORS FOR OZONE OXIDATION, OZONE OXIDIZING COMPOUND COMPOSITION, AND OZONE PROCESSING
TW200621799A (en) Acylated nonadepsipeptides II
PL1986502T3 (pl) Składniki aromatyzujące i metoda aromatyzacji produktów mlecznych, szczep bakterii mlekowych, zastosowanie powyższych składników, metody lub szczepu
ATE459602T1 (de) Polymorphe von atorvastatin-tert.-butylester und deren verwendung als zwischenprodukte für die herstellung von atorvastatin
MY150686A (en) Oral composition containing morin
WO2009059054A3 (en) Bacteria strains an d bacteriocin produced therefrom
WO2007146173A3 (en) A method for depletion of caries-causing bacteria in the oral cavity